DDX3X and cancer: An intense research effort has been made in recent years to identify DDX3X’s physiological mRNA targets in different cell types, driven by a desire to understand pathophysiology of the neurodevelopmental condition DDX3X syndrome and by the prospect that DDX3X inhibitors could serve as anti-viral and anti-cancer drugs.